Markets › India › NSE › NOVARTIND

Novartis India Ltd

NSE:NOVARTINDHealthcare

₹1,921.60+1.26%At closeAt close · Mon 19 Oct · ≈ AED 74.24 · Market cap $493.71M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	21.0%	19.6%	32.3%	32.6%	43.1%	37.5%	—	—
Operating margin	4.4%	4.6%	17.9%	19.7%	37.9%	26.0%	26.0%	+0.0 pts
Net margin	5.5%	−0.9%	27.3%	25.4%	28.3%	26.3%	26.3%	+0.0 pts
EBITDA margin	15.7%	2.7%	32.5%	37.9%	27.2%	26.6%	—	—
Return on equity	2.9%	−0.5%	13.3%	11.4%	12.9%	11.4%	11.4%	+0.0 pts
Return on assets	2.1%	−0.4%	10.5%	9.2%	10.6%	9.5%	9.5%	+0.0 pts
Return on capital employed	2.0%	2.5%	8.2%	8.6%	16.7%	11.1%	—	—
Debt / equity	0.1×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	6.2%	2.5%	2.2%	0.8%	0.5%	0.3%	—	—
Interest coverage	2.2×	3.8×	38.7×	44.4×	175.2×	73.1×	—	—
Current ratio	4.6×	3.3×	4.2×	4.4×	5.3×	5.3×	5.3×	+0.0%
Quick ratio	4.3×	3.0×	3.9×	4.2×	5.0×	4.9×	—	—
Cash ratio	0.4×	0.7×	0.1×	0.3×	0.4×	4.6×	4.6×	+0.0%
Asset turnover	0.4×	0.4×	0.4×	0.4×	0.4×	0.4×	—	—
Inventory turnover	3.1×	3.2×	3.7×	4.5×	4.9×	4.2×	—	—
Receivables turnover	4.5×	7.3×	7.6×	6.6×	7.2×	9.6×	—	—
Dividend payout	118.1%	−663.7%	23.9%	137.7%	61.2%	66.2%	—	—